西班牙Certest乙型流感病毒單抗（克隆YB91）
廣州健侖生物科技有限公司
廣州健侖長期供應各種生物原料，主要代理品牌：西班牙Certest。
Certest Biotec，S.L. 是一家獨立的生物技術公司，致力于人類臨床領域的IVD診斷產品的開發和制造。快速檢測是基于快速、準確和易于操作的診斷產品。 此外，Cerstest還有多種實時PCR產品，可以用于醫院臨床、實驗室科研等。
Certest公司于2002年在薩拉戈薩成立，是一家創新技術型公司。公司的發展是基于新產品的開發、市場空間和機遇的探索，十幾年來一直以高度專業化，以客戶為導向，不斷得創新，優化產品，專業知識，取得廣大客戶的信任和支持。Certest的質量體系已通過ISO 13485認證。
主要產品包括各種生物單克隆抗原抗體、重組蛋白。
輪狀病毒單克隆抗體、腺病毒抗體、星狀病毒單克隆抗體、諾如病毒單克隆抗體、幽門螺旋桿菌抗體、隱球菌抗體、腸道病毒抗體、賈第鞭毛蟲抗體、彎曲桿菌抗體、阿米巴原蟲抗體、呼吸道合胞病毒單抗等等。
西班牙Certest乙型流感病毒單抗（克隆YB91）
我司還提供其它進口或國產試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團菌、化妝品檢測、食品安全檢測等試劑盒以及日本生研細菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產品。
歡迎咨詢
歡迎咨詢2042552662
西班牙Certest公司簡介
Certest Biotec, S.L. is an independent biotechnology company devoted to the development and manufacturing of IVD diagnostic products in human clinical field. Our Rapid Test are based in a fast, reliable and easy-interpretation process. In addition, VIASURE contains a wide range of products for Real Time PCR that allow to identify the causal pathogens of the infectious diseases in physicians’ offices, labs and hospitals.
The company was established in Zaragoza in 2002 as an innovative and technology-based company. The company’s growth is based on the development of new products and the exploration for new market niches and opportunities. The key to understand its success is the way to understand its organization: highly specialised and customer-oriented based.
Mission, Vision, Values and Human Team
Mission
To develop, produce and market a wide range of innovative solutions and quality in vitro diagnostics for the detection of viruses, bacteria and parasites.
Vision
Being the international leader company in research and development for in vitro diagnostic solutions, increasing our distribution network through added value creation and company-customer trust.
Values
Customer orientation · Ethical behaviour · Teamwork · Continuous research and innovation ·Trained and motivated team · Quality and creativity in all processes
Human team
The multi-skilled team is a dedicated and experience professional group responsible for dealing with all the different company activities in an international environment.
Commitment to Innovation, Export and High-Technology.
Certest’s Quality System has been certified with ISO 13485.
One of the main objectives of Certest is to achieve customer satisfaction. For this, the management of the company ensures that customer requirements are determined and reviewed, identifying their needs and expectations, and translating them into requirements, all in order to maintain customer satisfaction.
See/Download the Certest Biotec ISO Standard Certification Certest Policy is consistent with its primary purpose, that of getting to all its products and services, quality and reliability, meeting the requirements and maintaining the effectiveness of the management system.
“Comparative study of two diagnostic tests for detection of RNA Zika Virus (ZIKV) in clinical samples”
“Comparison of Real-Time PCR test with the routine diagnosis technique to detect enteric pathogenic protozoa”
“Diagnostic of the Enteric Virus infection by Real-Time PCR in stool samples”
“Clinical performance evaluation of lyophilized VIASURE Real Time PCR Detection Kits for pathogen detection by participation in External Quality Assessment (EQA) programs”
“Detection and differentiation of Influenza A Virus, Influenza B Virus and H1N1 (pdm09) variant through an stabilized Real Time PCR Mix”
“Comparison of different molecular methods for the detection of non-influenza respiratory virus”virus”
【西班牙Certest生物原料】
貨號 | 產品名稱 | 規格 | 英文名稱 |
MT-16R15 | 輪狀病毒單克隆抗體（克隆R15） | x1mg | Anti-Rotavirus Mab (clone R15) |
MT-16R15s1 | 輪狀病毒單克隆抗體（克隆R15） | x100μg | Anti-Rotavirus Mab (clone R15) |
MT-18A15 | 腺病毒抗體（克隆A15） | x1mg | Anti-Adenovirus Mab (clone A15) |
MT-18A15s1 | 腺病毒抗體（克隆A15） | x100μg | Anti-Adenovirus Mab (clone A15) |
MT-18AT18 | 星狀病毒單克隆抗體（克隆AT18） | x1mg | Anti-Astrovirus Mab (clone AT18) |
MT-18AT18s1 | 星狀病毒單克隆抗體（克隆AT18） | x100μg | Anti-Astrovirus Mab (clone AT18) |
MT-18AT8 | 星狀病毒單克隆抗體（克隆AT8） | x1mg | Anti-Astrovirus Mab (clone AT8) |
MT-18AT8s1 | 星狀病毒單克隆抗體（克隆AT8） | x100μg | Anti-Astrovirus Mab (clone AT8) |
MT-18NG28 | 諾如病毒GI單克隆抗體（克隆NG28） | x1mg | Anti-Norovirus GI Mab (clone NG28) |
MT-18NG28sl | 諾如病毒GI單克隆抗體（克隆NG28） | x100μg | Anti-Norovirus GI Mab (clone NG28) |
MT-18NP8 | 諾如病毒GII單克隆抗體（克隆NP8） | x1mg | Anti-Norovirus GII Mab (clone NP8) |
MT-18NP8sl | 諾如病毒GII單克隆抗體（克隆NP8） | x100μg | Anti-Norovirus GII Mab (clone NP8) |
MT-18EV5 | 腸道病毒抗體（克隆EV5） | x1mg | Anti-Enterovirus Mab (clone EV5) |
MT-18EV5sl | 腸道病毒抗體（克隆EV5） | x100μg | Anti-Enterovirus Mab (clone EV5) |
MT-16P2 | 幽門螺旋桿菌抗體（克隆P2）HP抗體 | x1mg | Anti-H. pylori Mab (clone P2) |
MT-16P2sl | 幽門螺旋桿菌抗體（克隆P2）HP抗體 | x100μg | Anti-H. pylori Mab (clone P2) |
MT-16GD10 | 艱難梭菌抗體（克隆GD10） | x1mg | Anti-GDH Mab (clone GD10) |
MT-16GD10sl | 艱難梭菌抗體（克隆GD10） | x100μg | Anti-GDH Mab (clone GD10) |
MT-18TA5 | 艱難梭菌毒素A抗（克隆TA5） | x1mg | Anti-CD Toxin A Mab (clone TA5) |
MT-18TA5sl | 艱難梭菌毒素A抗（克隆TA5） | x100μg | Anti-CD Toxin A Mab (clone TA5) |
MT-18TA7 | 艱難梭菌毒素A抗（克隆TA7） | x1mg | Anti-CD Toxin A Mab (clone TA7) |
MT-18TA7sl | 艱難梭菌毒素A抗（克隆TA7） | x100μg | Anti-CD Toxin A Mab (clone TA7) |
MT-18TB41 | 艱難梭菌毒素B抗（克隆TB41） | x1mg | Anti-CD Toxin B Mab (clone TB41) |
MT-18TB41sl | 艱難梭菌毒素B抗（克隆TB41） | x100μg | Anti-CD Toxin B Mab (clone TB41) |
MT-18TB48 | 艱難梭菌毒素B抗（克隆TB48） | x1mg | Anti-CD Toxin B Mab (clone TB48) |
MT-18TB48sl | 艱難梭菌毒素B抗（克隆TB48） | x100μg | Anti-CD Toxin B Mab (clone TB48) |
MT-18E10 | 大腸桿菌O157抗體（克隆E10） | x1mg | Anti-E. coli O157 Mab (clone E10) |
MT-18E10sl | 大腸桿菌O157抗體（克隆E10） | x100μg | Anti-E. coli O157 Mab (clone E10) |
MT-16CA29 | 彎曲桿菌抗體（克隆ECA29） | x1mg | Anti-Campylobacter Mab (clone CA29) |
MT-16CA29sl | 彎曲桿菌抗體（克隆ECA29） | x100μg | Anti-Campylobacter Mab (clone CA29) |
MT-18K31 | 隱球菌抗體（克隆K31） | x1mg | Anti-Crypto Mab (clone K31) |
MT-18K31sl | 隱球菌抗體（克隆K31） | x100μg | Anti-Crypto Mab (clone K31) |
MT-16G18 | 賈第鞭毛蟲抗體（克隆G18） | x1mg | Anti-Giardia Mab trophozoite protein (clone G18) |
MT-16G18sl | 賈第鞭毛蟲抗體（克隆G18） | x100μg | Anti-Giardia Mab trophozoite protein (clone G18) |
MT-16G22 | 賈第鞭毛蟲抗體（克隆G22） | x1mg | Anti-Giardia Mab trophozoite protein (clone G22) |
MT-16G22sl | 賈第鞭毛蟲抗體（克隆G22） | x100μg | Anti-Giardia Mab trophozoite protein (clone G22) |
MT-18EH30 | 阿米巴原蟲抗體（克隆H30） | x1mg | Anti-Entamoeba Mab (clone EH30) |
MT-18EH30sl | 阿米巴原蟲抗體（克隆H30） | x100μg | Anti-Entamoeba Mab (clone EH30) |
MT-16CP14 | 鈣結合蛋白單克隆抗體（克隆CP14） | x1mg | Anti-Calprotectin Mab (clone CP14) |
MT-16CP14sl | 鈣結合蛋白單克隆抗體（克隆CP14） | x100μg | Anti-Calprotectin Mab (clone CP14) |
MT-16F22 | 血紅蛋白單抗（克隆F22） | x1mg | Anti-Haemoglobin Mab (clone F22) |
MT-16F22sl | 血紅蛋白單抗（克隆F22） | x100μg | Anti-Haemoglobin Mab (clone F22) |
MT-16LC16 | 乳鐵蛋白單抗（克隆LC16） | x1mg | Anti-Lactoferrin Mab (clone LC16) |
MT-16LC16sl | 乳鐵蛋白單抗（克隆LC16） | x100μg | Anti-Lactoferrin Mab (clone LC16) |
MT-16LC4 | 乳鐵蛋白單抗（克隆LC4） | x1mg | Anti-Lactoferrin Mab (clone LC4) |
MT-16LC4sl | 乳鐵蛋白單抗（克隆LC4） | x100μg | Anti-Lactoferrin Mab (clone LC4) |
MT-26VP6 | 輪狀病毒VP6重組蛋白 | x1mg | Rotavirus VP6 recombinant protein |
MT-26VP6 | 輪狀病毒VP6重組蛋白 | x100μg | Rotavirus VP6 recombinant protein |
MT-25HEX | 腺病毒HEXON重組蛋白 | x1mg | Adenovirus HEXON recombinant protein |
MT-25HEXsl | 腺病毒HEXON重組蛋白 | x100μg | Adenovirus HEXON recombinant protein |
MT-25AST | 星狀病毒衣殼重組蛋白 | x1mg | Astrovirus capsid recombinant protein |
MT-25ASTsl | 星狀病毒衣殼重組蛋白 | x100μg | Astrovirus capsid recombinant protein |
MT-25NGI1 | 諾如病毒GI.1重組P結構域 | x1mg | Norovirus GI.1 recombinant P domain |
MT-25NGI1sl | 諾如病毒GI.1重組P結構域 | x100μg | Norovirus GI.1 recombinant P domain |
MT-25NGI3 | 諾如病毒GI.3重組P結構域 | x1mg | Norovirus GI.3 recombinant P domain |
MT-25NGI3sl | 諾如病毒GI.3重組P結構域 | x100μg | Norovirus GI.3 recombinant P domain |
MT-25NGII10 | 諾如病毒GII.10重組P結構域 | x1mg | Norovirus GII.10 recombinant P domain |
MT-25NGII10sl | 諾如病毒GII.10重組P結構域 | x100μg | Norovirus GII.10 recombinant P domain |
MT-25NGII17 | 諾如病毒GII.17重組P結構域 | x1mg | Norovirus GII.17 recombinant P domain |
MT-25NGII17sl | 諾如病毒GII.17重組P結構域 | x100μg | Norovirus GII.17 recombinant P domain |
MT-25NGII14 | 諾如病毒GII.4重組P結構域 | x1mg | Norovirus GII.4 recombinant P domain |
MT-25NGII14sl | 諾如病毒GII.4重組P結構域 | x100μg | Norovirus GII.4 recombinant P domain |
MT-25ETV | 腸道病毒VP1重組蛋白 | x1mg | Enterovirus VP1 recombinant protein |
MT-25ETVs1 | 腸道病毒VP1重組蛋白 | x100μg | Enterovirus VP1 recombinant protein |
MT-25PCH | 幽門螺桿菌重組外膜蛋白 | x1mg | H. pylori recombinant outer membrane protein |
MT-25PCHs1 | 幽門螺桿菌重組外膜蛋白 | x100μg | H. pylori recombinant outer membrane protein |
MT-25GDH | 艱難梭菌GDH重組蛋白 | x1mg | Clostridium difficile GDH recombinant protein |
MT-25GDHsl | 艱難梭菌GDH重組蛋白 | x100μg | Clostridium difficile GDH recombinant protein |
MT-24TXA | 艱難梭菌毒素A重組蛋白（無毒性片段） | x1mg | C. difficile Toxin A recombinant protein (fragment without toxic activity) |
MT-24TXAsl | 艱難梭菌毒素A重組蛋白（無毒性片段） | x100μg | C. difficile Toxin A recombinant protein (fragment without toxic activity) |
MT-24TXB | 艱難梭菌毒素B重組蛋白（無毒性片段） | x1mg | C. difficile Toxin B recombinant protein (fragment without toxic activity) |
MT-24TXBsl | 艱難梭菌毒素B重組蛋白（無毒性片段） | x100μg | C. difficile Toxin B recombinant protein (fragment without toxic activity) |
MT-25STX | 大腸桿菌O157 VT1重組蛋白 | x1mg | E. coli O157 VT1 recombinant protein |
MT-25STXsl | 大腸桿菌O157 VT1重組蛋白 | x100μg | E. coli O157 VT1 recombinant protein |
MT-25VT2 | 大腸桿菌O157 VT2重組蛋白 | x1mg | E. coli O157 VT2 recombinant protein |
MT-25VT2sl | 大腸桿菌O157 VT2重組蛋白 | x100μg | E. coli O157 VT2 recombinant protein |
MT-25CCP | 彎曲桿菌重組外膜蛋白 | x1mg | Campylobacter coli recombinant outer membrane protein |
MT-25CCPsl | 彎曲桿菌重組外膜蛋白 | x100μg | Campylobacter coli recombinant outer membrane protein |
MT-25CEP | 空腸彎曲桿菌重組外膜蛋白 | x1mg | Campylobacter jejuni recombinant outer membrane protein |
MT-25CEPsl | 空腸彎曲桿菌重組外膜蛋白 | x100μg | Campylobacter jejuni recombinant outer membrane protein |
MT-25A1G | 賈第蟲腸道滋養體重組蛋白 | x1mg | Giardia intestinalis trophozoite recombinant protein |
MT-25A1Gsl | 賈第蟲腸道滋養體重組蛋白 | x100μg | Giardia intestinalis trophozoite recombinant protein |
MT-25GCP | 賈第蟲腸囊菌重組蛋白 | x1mg | Giardia intestinalis cyst recombinant protein |
MT-25GCPsl | 賈第蟲腸囊菌重組蛋白 | x100μg | Giardia intestinalis cyst recombinant protein |
MT-25EDP | 內阿米巴重組蛋白 | x1mg | Entamoeba dispar recombinant protein |
MT-25EDPsl | 內阿米巴重組蛋白 | x100μg | Entamoeba dispar recombinant protein |
MT-25EHP | 溶組織內阿米巴重組蛋白 | x1mg | Entamoeba histolytica recombinant protein |
MT-25EHPsl | 溶組織內阿米巴重組蛋白 | x100μg | Entamoeba histolytica recombinant protein |
MT-25HCP | 人類鈣衛蛋白重組蛋白 | x1mg | Human Calprotectin recombinant protein |
MT-25HCPs1 | 人類鈣衛蛋白重組蛋白 | x100μg | Human Calprotectin recombinant protein |
MT-31NGA | 諾如病毒GI.1重組VLP | x1mg | Norovirus GI.1 recombinant VLP |
MT-31NGAsl | 諾如病毒GI.1重組VLP | x100μg | Norovirus GI.1 recombinant VLP |
MT-31NPA | 諾如病毒GII.4重組VLP | x1mg | Norovirus GII.4 recombinant VLP |
MT-31NPAsl | 諾如病毒GII.4重組VLP | x100μg | Norovirus GII.4 recombinant VLP |
MT-28PECU | 滅活的幽門螺桿菌抗原（天然提取物） | x1mg | Inactivated H. pylori antigen (native extract) |
MT-28PECUsl | 滅活的幽門螺桿菌抗原（天然提取物） | x100μg | Inactivated H. pylori antigen (native extract) |
MT-28EC7U | 滅活的大腸桿菌O157抗原（天然提取物） | x1mg | Inactivated E. coli O157 antigen (native extract) |
MT-28EC7Usl | 滅活的大腸桿菌O157抗原（天然提取物） | x100μg | Inactivated E. coli O157 antigen (native extract) |
MT-28CCU | 滅活的大腸桿菌抗原（天然提取物） | x1mg | Inactivated Campylobacter coli antigen (native extract) |
MT-28CCUsl | 滅活的大腸桿菌抗原（天然提取物） | x100μg | Inactivated Campylobacter coli antigen (native extract) |
MT-28CJU | 滅活的空腸彎曲桿菌抗原（天然提取物） | x1mg | Inactivated Campylobacter jejuni antigen (native extract) |
MT-28CJUsl | 滅活的空腸彎曲桿菌抗原（天然提取物） | x100μg | Inactivated Campylobacter jejuni antigen (native extract) |
MT-28SEU | 滅活腸炎沙門氏菌抗原（天然提取物） | x1mg | Inactivated Salmonella enteritidis antigen (native extract) |
MT-28SEUs1 | 滅活腸炎沙門氏菌抗原（天然提取物） | x100μg | Inactivated Salmonella enteritidis antigen (native extract) |
MT-28SPAU | 滅活沙門氏菌副傷寒A抗原（天然提取物） | x1mg | Inactivated Salmonella paratyphi A antigen (native extract) |
MT-28SPAUsl | 滅活沙門氏菌副傷寒A抗原（天然提取物） | x100μg | Inactivated Salmonella paratyphi A antigen (native extract) |
MT-28SPBU | 滅活沙門氏菌副傷寒B抗原（天然提取物） | x1mg | Inactivated Salmonella paratyphi B antigen (native extract) |
MT-28SPBUsl | 滅活沙門氏菌副傷寒B抗原（天然提取物） | x100μg | Inactivated Salmonella paratyphi B antigen (native extract) |
MT-28STMU | 滅活的鼠傷寒沙門氏菌抗原（天然提取物） | x1mg | Inactivated Salmonella typhimurium antigen (native extract) |
MT-28STMUsl | 滅活的鼠傷寒沙門氏菌抗原（天然提取物） | x100μg | Inactivated Salmonella typhimurium antigen (native extract) |
MT-28STU | 滅活傷寒沙門氏菌抗原（天然提取物） | x1mg | Inactivated Salmonella typhi antigen (native extract) |
MT-28STUsl | 滅活傷寒沙門氏菌抗原（天然提取物） | x100μg | Inactivated Salmonella typhi antigen (native extract) |
MT-28LMU | 滅活的單核細胞增生李斯特菌抗原（天然提取物） | x1mg | Inactivated Listeria monocytogenes antigen (native extract) |
MT-28LMUsl | 滅活的單核細胞增生李斯特菌抗原（天然提取物） | x100μg | Inactivated Listeria monocytogenes antigen (native extract) |
MT-28YE3U | 滅活小腸結腸炎耶爾森氏菌O:3抗原（天然提取物） | x1mg | Inactivated Yersinia enterocolitica O:3 antigen (native extract) |
MT-28YE3Usl | 滅活小腸結腸炎耶爾森氏菌O:3抗原（天然提取物） | x100μg | Inactivated Yersinia enterocolitica O:3 antigen (native extract) |
MT-28YE9U | 滅活小腸結腸炎耶爾森氏菌O:9抗原（天然提取物） | x1mg | Inactivated Yersinia enterocolitica O:9 antigen (native extract) |
MT-28YE9Usl | 滅活小腸結腸炎耶爾森氏菌O:9抗原（天然提取物） | x100μg | Inactivated Yersinia enterocolitica O:9 antigen (native extract) |
MT-28SBU | 滅活的鮑氏志賀氏菌抗原（天然提取物） | x1mg | Inactivated Shigella boydii antigen (native extract) |
MT-28SBUsl | 滅活的鮑氏志賀氏菌抗原（天然提取物） | x100μg | Inactivated Shigella boydii antigen (native extract) |
MT-28SDU | 滅活的痢疾志賀氏菌抗原（天然提取物） | x1mg | Inactivated Shigella dysenteriae antigen (native extract) |
MT-28SDUsl | 滅活的痢疾志賀氏菌抗原（天然提取物） | x100μg | Inactivated Shigella dysenteriae antigen (native extract) |
MT-28SFU | 滅活的福氏志賀氏菌抗原（天然提取物） | x1mg | Inactivated Shigella flexneri antigen (native extract) |
MT-28SFUdl | 滅活的福氏志賀氏菌抗原（天然提取物） | x100μg | Inactivated Shigella flexneri antigen (native extract) |
MT-28SSU | 滅活的宋內氏志賀菌抗原（天然提取物） | x1mg | Inactivated Shigella sonnei antigen (native extract) |
MT-28SSUsl | 滅活的宋內氏志賀菌抗原（天然提取物） | x100μg | Inactivated Shigella sonnei antigen (native extract) |
MT-29KOE | 滅活小球隱孢子蟲抗原（天然提取物） | x1mg | Inactivated Cryptosporidium parvum antigen (native extract) |
MT-29KOEsl | 滅活小球隱孢子蟲抗原（天然提取物） | x100μg | Inactivated Cryptosporidium parvum antigen (native extract) |
MT-29HHB | 人血紅蛋白蛋白質（天然提取物） | x1mg | Human Haemoglobin protein (native extract) |
MT-29HHBsl | 人血紅蛋白蛋白質（天然提取物） | x100μg | Human Haemoglobin protein (native extract) |
MT-29HLF | 人乳鐵蛋白蛋白質（天然提取物） | x1mg | Human Lactoferrin protein (native extract) |
MT-29HLF | 人乳鐵蛋白蛋白質（天然提取物） | x100μg | Human Lactoferrin protein (native extract) |
MT-29HTF | 人轉鐵蛋白蛋白質（天然提取物） | x1mg | Human Transferrin protein (native extract) |
MT-29HTFsl | 人轉鐵蛋白蛋白質（天然提取物） | x100μg | Human Transferrin protein (native extract) |
MT-20TSS | 溶血性A鏈球菌抗體 | x1mg | Anti-Strep A Pab |
MT-20TSSsl | 溶血性A鏈球菌抗體 | x100μg | Anti-Strep A Pab |
MT-18RV3 | 呼吸道合胞病毒單抗（克隆RV3） | x1mg | Anti-RSV Mab (clone RV3) |
MT-18RV3sl | 呼吸道合胞病毒單抗（克隆RV3） | x100μg | Anti-RSV Mab (clone RV3) |
MT-18RV4 | 呼吸道合胞病毒單抗（克隆RV4） | x1mg | Anti-RSV Mab (clone RV4) |
MT-18RV4sl | 呼吸道合胞病毒單抗（克隆RV4） | x100μg | Anti-RSV Mab (clone RV4) |
MT-18A14 | 腺病毒單克隆抗體（克隆A14） | x1mg | Anti-Adenovirus Mab (clone A14) |
MT-18A14sl | 腺病毒單克隆抗體（克隆A14） | x100μg | Anti-Adenovirus Mab (clone A14) |
MT-18A15 | 腺病毒單克隆抗體（克隆A15） | x1mg | Anti-Adenovirus Mab (clone A15) |
MT-18A15Rsl | 腺病毒單克隆抗體（克隆A15） | x100μg | Anti-Adenovirus Mab (clone A15) |
MT-18Y77 | 甲型流感病毒單抗（克隆Y77） | x1mg | Anti-Influenza A Mab (clone Y77) |
MT-18Y77sl | 甲型流感病毒單抗（克隆Y77） | x100μg | Anti-Influenza A Mab (clone Y77) |
MT-18YB91 | 乙型流感病毒單抗（克隆YB91） | x1mg | Anti-Influenza B Mab (clone YB91) |
MT-18YB91sl | 乙型流感病毒單抗（克隆YB91） | x100μg | Anti-Influenza B Mab (clone YB91) |
MT-18LN14 | 嗜肺軍團菌單抗(克隆LN14) | x1mg | Anti-Legionella pneumophila Mab (clone LN14) |
MT-18LN14sl | 嗜肺軍團菌單抗(克隆LN14) | x100μg | Anti-Legionella pneumophila Mab (clone LN14) |
MT-18LN29 | 嗜肺軍團菌單抗(克隆LN29) | x1mg | Anti-Legionella pneumophila Mab (clone LN29) |
MT-18LN29sl | 嗜肺軍團菌單抗(克隆LN29) | x100μg | Anti-Legionella pneumophila Mab (clone LN29) |
MT-18SN3 | 肺炎鏈球菌單克隆抗體(克隆SN3) | x1mg | Anti-Streptococcus pneumoniae Mab (clone SN3) |
MT-18SN3s1 | 肺炎鏈球菌單克隆抗體(克隆SN3) | x100μg | Anti-Streptococcus pneumoniae Mab (clone SN3) |
MT-18SN4 | 肺炎鏈球菌單克隆抗體(克隆SN4) | x1mg | Anti-Streptococcus pneumoniae Mab (clone SN4) |
MT-18SN4sl | 肺炎鏈球菌單克隆抗體(克隆SN4) | x100μg | Anti-Streptococcus pneumoniae Mab (clone SN4) |
MT-25RSV | 呼吸道合胞病毒重組融合蛋白 | x1mg | RSV recombinant fusion protein |
MT-25RSVsl | 呼吸道合胞病毒重組融合蛋白 | x100μg | RSV recombinant fusion protein |
MT-25HEXR | 腺病毒六鄰體重組蛋白 | x1mg | Adenovirus HEXON recombinant protein |
MT-25HEXRsl | 腺病毒六鄰體重組蛋白 | x100μg | Adenovirus HEXON recombinant protein |
MT-25FAN | 甲型流感病毒重組核蛋白 | x1mg | Influenza A recombinant nucleoprotein |
MT-25FANsl | 甲型流感病毒重組核蛋白 | x100μg | Influenza A recombinant nucleoprotein |
MT-25FBN | 乙型流感病毒重組核蛋白 | x1mg | Influenza B recombinant nucleoprotein |
MT-25FBNsl | 乙型流感病毒重組核蛋白 | x100μg | Influenza B recombinant nucleoprotein |
MT-28SAGU | 滅活A鏈球菌抗原（天然提取物） | x1mg | Inactivated STREP A antigen (native extract) |
MT-28SAGUsl | 滅活A鏈球菌抗原（天然提取物） | x100μg | Inactivated STREP A antigen (native extract) |
MT-29RVV | 滅活呼吸道合胞病毒抗原（天然提取物） | x1mg | Inactivated RSV antigen (native extract) |
MT-29RVVsl | 滅活呼吸道合胞病毒抗原（天然提取物） | x100μg | Inactivated RSV antigen (native extract) |
MT-28LNU | 滅活的嗜肺軍團菌抗原（天然提取物） | x1mg | Inactivated Legionella pneumophila antigen (native extract) |
MT-28LNUsl | 滅活的嗜肺軍團菌抗原（天然提取物） | x100μg | Inactivated Legionella pneumophila antigen (native extract) |
MT-28SPNU | 滅活的肺炎鏈球菌抗原（天然提取物） | x1mg | Inactivated Streptococcus pneumoniae antigen (native extract) |
MT-28SPNUsl | 滅活的肺炎鏈球菌抗原（天然提取物） | x100μg | Inactivated Streptococcus pneumoniae antigen (native extract) |
西班牙
3、代謝組學(metabonomics/metabolomics)
定性和定量分析特定條件下的特定生物樣品中所有代謝物組分。在分析方法上，樣品預處理和檢測要滿足對所有代謝物組分的檢測，因此要保證高靈敏度、高選擇性、高通量的要求。龐大的數據結果需要利用化學計量學技術進行數據的解析。
4、代謝指紋分析(metabolic fingerprinting analysis)
高通量定性分析所有的代謝物，以此描述某種生理狀態的各種代謝類型的變化。該方法一般不進行定量分析。
生物復雜系統的研究既要求對目標化合物的精確定量分析（靶標分析）又需要對系統整體的定性評價（全局分析），這對分析技術提出了挑戰：一方面，現有的面向靶標分析的方法與面向系統的整體分析（全面性）存在矛盾；另一方面，樣品的復雜性反過來影響了靶標分析的可靠性（特異性）。
至今為止，還沒有一種方法可以真正準確測定所有的代謝物，因此往往將代謝組學不同層次的方法相結合，一方面對于代謝物全譜作全面的分析，另一方面用靶標分析的方法補充全局分析的不足，從而達到分析盡可能多的代謝組分的研究目的。
構建系統進化樹的理論方法主要有基于距離的方法UPGMA、ME（Minimum Evolution，zui小進化法）和NJ（Neighbor-Joining，鄰接法）等。此外，還包括MP（Maximum parsimony，zui大簡約法）、ML（Maximum likelihood，zui大似然法）以及貝葉斯（Bayesian）推斷等方法。其中UPGMA法已經較少使用。下面對其中zui常用的3種方法簡要介紹。
1、鄰接法（Neighbor-Joining，NJ）：
該方法通過確定距離zui近或相鄰的成對分類單位來使系統樹的總距離達到zui小。相鄰是指兩個分類單位在某一無根分叉樹中僅通過一個節點（Node）相連。通過循序地將相鄰點合并成新的點，就可以建立一個相應的拓撲樹。
2、zui大似然法（Maximum likelihood，ML）：
zui早應用于系統發育分析是在對基因頻率數據的分析上，后來基于分子序列的分析中也引入了zui大似然法的分析方法。zui大似然法分析中，選取一個特定的替代模型來分析給定的一組序列數據，使得獲得的每一個拓撲結構的似然率都為zui大值，然后再挑出其中似然率zui大的拓撲結構作為*樹。在zui大似然法的分析中，所考慮的參數并不是拓撲結構而是每個拓撲結構的枝長，并對似然率球zui大值來估計枝長。zui大似然法的建樹過程是個很費時的過程，因為在分析過程中有很大的計算量，每個步驟都要考慮內部節點的所有可能性。zui大似然法也是一個比較成熟的參數估計的統計學方法，具有很好的統計學理論基礎，在當樣本量很大的時候，似然法可以獲得參數統計的zui小方差。只要使用了一個合理的、正確的替代模型，zui大似然法可以推導出一個很好的進化樹結果。
西班牙
我司還提供其它進口或國產試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團菌、食品安全、化妝品檢測、藥物濫用檢測等試劑盒以及日本生研細菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產品。
想了解更多的產品及服務請掃描下方二維碼：
【公司名稱】 廣州健侖生物科技有限公司
【市場部】 楊永漢
【】
【騰訊 】 2042552662
【公司地址】 廣州清華科技園創新基地番禺石樓鎮創啟路63號二期2幢101-103室
3, Metabolomics (metabonomics / metabolomics)
Qualitatively and quantitatively analyze all metabolite components in a specific biological sample under specific conditions. In the analytical method, sample preparation and testing to meet the detection of all metabolite components, so to ensure high sensitivity, high selectivity, high throughput requirements. Large data results require the use of chemometrics techniques for data analysis.
4, metabolic fingerprinting analysis (metabolic fingerprinting analysis)
High-throughput qualitative analysis of all metabolites, in order to describe a variety of physiological state of the various metabolic changes. This method is generally not quantitative analysis.
The research of biological complex system not only requires the accurate quantitative analysis (target analysis) but also the qualitative evaluation (global analysis) of the target compound, which poses a challenge to the analytical technique. On the one hand, the existing target-oriented analysis method Contradictory to the overall system-oriented analysis (comprehensiveness); on the other hand, the complexity of the sample in turn affects the reliability (specificity) of the target analysis.
To date, there is no single method for truly accurate determination of all metabolites. Therefore, methods at different levels of metabolomics are often combined to provide a comprehensive analysis of the full spectrum of metabolites on the one hand, and methods of target analysis on the other Complement the deficiencies of global analysis, so as to achieve the purpose of analyzing as many metabolic components as possible.
The theoretical methods of constructing phylogenetic tree mainly include distance-based methods UPGMA, ME (Minimum Evolution) and NJ (Neighbor-Joining). In addition, methods such as MP (Maximum parsimony), ML (Maximum likelihood) and Bayesian inference are also included. Which UPGMA method has been less used. Here's a brief introduction of the three most commonly used methods.
1, Neighbor-Joining (NJ):
The method minimizes the total distance of the system tree by determining the nearest or adjacent pairs of taxa. Adjacent means that two taxa are connected by only one node in a rootless-bifurcated tree. By sequentially merging adjacent points into new points, a corresponding topological tree can be established.
2, Maximum likelihood method (ML):
The earliest application in phylogenetic analysis was based on the analysis of gene frequency data. Later analysis based on molecular sequences also introduced the method of maximum likelihood analysis. In the maximum likelihood analysis, a specific alternative model is selected to analyze a given set of sequence data such that the likelihood of each topology obtained is the maximum, and then the one with the highest likelihood is singled out Structure as the optimal tree. In the analysis of the maximum likelihood method, the parameter under consideration is not the topology but the branch length of each topology, and the branch length is estimated from the maximum value of the likelihood sphere. The process of establishing the maximum likelihood method is a time-consuming process because of the large amount of computation involved in the analysis and each step taking into account all the possibilities of internal nodes. The maximum likelihood method is also a relatively mature statistical method of parameter estimation. It has a good statistical theory foundation. When the sample size is very large, the likelihood method can obtain the minimum variance of the parameter statistics. As long as a reasonable and correct alternative model is used, the maximum likelihood method can derive a good evolutionary tree result.
